AMD’s revenue surged 14% in 2024, with its AI data center business contributing significantly to this growth, reaching over ...

Advanced Micro Devices (NASDAQ:AMD) finds itself at a critical juncture in the semiconductor industry, with significant opportunities in the burgeoning artificial intelligence (AI) market balanced ...

Advanced Micro Devices' Q4 results show 24% revenue growth and 42% EPS increase, yet the stock dropped 10%. See why I ...

Clearside Biomedical, Inc. (NASDAQ:CLSD), currently valued at $81.15 million, is a biotechnology company focused on developing innovative therapies for blinding eye diseases using its proprietary SCS ...

Advanced Micro Devices (NASDAQ:AMD) has long played second fiddle to Nvidia (NASDAQ:NVDA) in the AI chip race, struggling to gain ground. But ...

The tech sector marks a major turning point today with stories of Intel possibly being sold off and TSMC and Broadcom showing ...

Rasgon maintained a market-perform rating on both chip stocks, with a price target of $125 on AMD and $25 on Intel. Shares of AMD were up 1.6% in morning trading, while Intel continued toward another ...

Intel Corporation, Qualcomm Incorporated, NVIDIA Corporation, Advanced Micro Devices Inc. Read The Tokenist (Timothy Fries)'s ...

We ran that screen on Feb. 15 last year, using data as of the market close the previous day. Nvidia's (NVDA) stock has returned 80% from Feb. 14, 2024, through Tuesday, while the S&P 500 SPX has ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...